Does sulphinpyrazone reduce haemolysis from prosthetic heart valves?
Errington
M
M
Department of Medical Radiology, Royal Infirmary, Edinburgh, Scotland.
Bloomfield
P
P
D000368:Aged; D000743:Anemia, Hemolytic / Q000188:drug therapy / Q000209:etiology; D001705:Bioprosthesis / Q000009:adverse effects; D005260:Female; D006350:Heart Valve Prosthesis / Q000009:adverse effects; D006461:Hemolysis / Q000187:drug effects*; D006801:Humans; D008297:Male; D008875:Middle Aged; D013442:Sulfinpyrazone / Q000627:therapeutic use*
D013442:Sulfinpyrazone